1. Azuma Kosai, Nanao Horike, Yoshiaki Takei, Akihiro Yamashita, Kaori Fujita, Takashi Kamatani, Noriyuki Tsumaki, Changes in acetyl-CoA mediate Sik3-induced maturation of chondrocytes in endochondral bone formation, Biochemical and Biophysical Research Communications, 2019, 516,4,1097-1102, https://doi.org/10.1016/j.bbrc.2019.06.139.
2. Yamamoto K, Kawai M, Yamazaki M, Tachikawa K, Kubota T, Ozono K, Michigami T. CREB activation in hypertrophic chondrocytes is involved in the skeletal overgrowth in epiphyseal chondrodysplasia Miura type caused by activating mutations of natriuretic peptide receptor B. Hum Mol Genet,2019, 28(7), 1183-1198, DOI: 10.1093/hmg/ddy428
3. Ohata Y, Takeyari S, Nakano Y, Kitaoka T, Nakayama H, Bizaoui V, Yamamoto K, Miyata K, Yamamoto K, Fujiwara M, Kubota T, Michigami T, Yamamoto K, Yamamoto T, Namba N, Ebina K, Yoshikawa H, Ozono K. Comprehensive genetic analyses using targeted next-generation sequencing and genotype-phenotype correlations in 53 Japanese patients with osteogenesis imperfecta. Osteoporos Int,2019, 30(11), 2333-2342, DOI: 10.1007/s00198-019-05076-6
4. Nakano C, Kitabatake Y, Takeyari S, Ohata Y, Kubota T, Taketani K, Kogo M, Ozono K. Genetic correction of induced pluripotent stem cells mediated by transcription activator-like effector nucleases targeting ALPL recovers enzyme activity and calcification in vitro. Mol Genet Metab,2019, 127(2), 158-165, DOI: 10.1016/j.ymgme.2019.05.014
5. Michigami T, Tachikawa K, Yamazaki M, Kawai M, Kubota T, Ozono K. Hypophosphatasia in Japan: ALPL Mutation Analysis in 98 Unrelated Patients. Calcif Tissue Int,2020, 106 (3),221-231, DOI: 10.1007/s00223-019-00626-w
6. Kubota T, Adachi M, Kitaoka T, Hasegawa K, Ohata Y, Fujiwara M, Michigami T, Mochizuki H, Ozono K. Clinical practice guidelines for achondroplasia. Clin Pediatr Endocrinol,2020, 29(1), 25-42,DOI: 10.1297/cpe.29.25
7. Yamamoto K, Kubota T, Takeyari S, Kitaoka T, Miyata K, Nakano Y, Nakayama H, Ohata Y, Yanagi K, Kaname T, Okada Y, Ozono K. Parental somatogonadal COL2A1 mosaicism contributes to intrafamilial recurrence in a family with type 2 collagenopathy. Am J Med Genet A,2020, 182(3), 454-460,DOI: 10.1002/ajmg.a.61422
8. 大薗恵一,窪田拓生. 軟骨無形成症診療ガイドラインについて教えてください,2020成長障害診療Q&A
9. Ueda M, Tsubamoto H, Kashima-Morii M, Torii Y, Kamihigashi M, Wakimoto Y, Nakagomi N, Hashimoto-Tamaoki T, Sawai H, Shibahara H. Challenges in Managing Patients with Hereditary Cancer at Gynecological Services. Obstet Gynecol Int. 2019;2019:4365754. doi: 10.1155/2019/4365754. eCollection 2019. 201905
10. Sawai H, Oka K, Ushioda M, Nishimura G, Omori T, Numabe H, Kosugi S. National survey of prevalence and prognosis of thanatophoric dysplasia in Japan. Pediatr Int. 2019 Aug;61(8):748-753. doi: 10.1111/ped.13927. Epub 2019 Aug 27.201908